In a recent development, the Supreme Court has adopted a firm position against the Indian government’s lack of action concerning Patanjali Ayurveda Limited’s misleading advertising practices. This move comes after a petition was filed by a consumer rights group, seeking action against the company for misleading and false claims in their advertisements.
The Supreme Court bench, comprising Justices D.Y. Chandrachud and Surya Kant, expressed its dismay at the lack of response from the Centre and the Food Safety and Standards Authority of India (FSSAI) in addressing the issue. The bench pointed out that the company has been making false claims about its products, particularly its immunity-boosting products, which have gained popularity during the COVID-19 pandemic.
The court’s remarks come in the wake of a Public Interest Litigation (PIL) filed by the Centre for Public Interest Litigation (CPIL), a non-governmental organization working on consumer rights. The PIL alleges that Patanjali has been making exaggerated and unsubstantiated claims about the effectiveness of its products in boosting immunity and preventing COVID-19.
The CPIL has also accused the company of violating the Food Safety and Standards Act, 2006, and the Food Safety and Standards (Advertising and Claims) Regulations, 2018. The PIL contends that Patanjali has been selling its products with misleading labels and advertisements, which falsely claim that the products can cure or prevent COVID-19.
The CPIL has further alleged that the government has failed to act against the company, despite numerous complaints and representations. The petitioner has sought directions from the court to the government and the FSSAI to take immediate action against Patanjali and ensure that it stops making false claims in its advertisements.
The Supreme Court has issued notices to the Centre, the FSSAI, and Patanjali, seeking their responses to the allegations made in the PIL. The court has also directed the government to produce the records related to the approvals granted to Patanjali for its products and advertisements.
The court’s intervention in this matter is significant as it underscores the importance of protecting consumers from false and misleading advertisements. In this case, the court’s scrutiny of the government’s inaction sends a strong message that it will not tolerate companies taking advantage of consumers by making false claims about their products.
The case also highlights the need for stricter enforcement of regulations governing advertising and product claims. In recent years, there has been a growing concern about the proliferation of misleading advertisements in various sectors, including healthcare and wellness products.
The Patanjali case serves as a wake-up call for the government and regulatory authorities to step up their efforts to crack down on false advertising. It is essential to ensure that consumers are not misled by exaggerated or unsubstantiated claims about the efficacy of products.
The Supreme Court’s involvement in the Patanjali case is a commendable move towards safeguarding consumers from deceptive and inaccurate marketing. The court’s scrutiny of the government’s inaction sends a strong message that companies cannot get away with making false claims about their products. It is now up to the government and regulatory authorities to take swift action against Patanjali and other companies engaged in similar practices.
